Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.

Nguyen HT, Pohar KS, Jia G, Shah ZK, Mortazavi A, Zynger DL, Wei L, Clark D, Yang X, Knopp MV.

Invest Radiol. 2014 Jun;49(6):390-5. doi: 10.1097/RLI.0000000000000022.

2.

Dynamic contrast-enhanced MRI for prostate cancer localization.

Jackson AS, Reinsberg SA, Sohaib SA, Charles-Edwards EM, Jhavar S, Christmas TJ, Thompson AC, Bailey MJ, Corbishley CM, Fisher C, Leach MO, Dearnaley DP.

Br J Radiol. 2009 Feb;82(974):148-56. doi: 10.1259/bjr/89518905.

PMID:
19168692
3.

Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.

Pinker K, Bogner W, Baltzer P, Gruber S, Bickel H, Brueck B, Trattnig S, Weber M, Dubsky P, Bago-Horvath Z, Bartsch R, Helbich TH.

Invest Radiol. 2014 Jun;49(6):421-30. doi: 10.1097/RLI.0000000000000029.

PMID:
24566292
5.

Interest of diffusion-weighted and gadolinium-enhanced dynamic MR sequences for the diagnosis of parotid gland tumors.

Lechner Goyault J, Riehm S, Neuville A, Gentine A, Veillon F.

J Neuroradiol. 2011 May;38(2):77-89. doi: 10.1016/j.neurad.2009.10.005.

6.

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.

Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.

Acta Radiol. 2008 Dec;49(10):1207-13. doi: 10.1080/02841850802508959.

PMID:
19031184
7.

Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI.

Wu LM, Chen XX, Xu JR, Zhang XF, Suo ST, Yao QY, Fan Y, Hu J.

Acad Radiol. 2013 Aug;20(8):939-46. doi: 10.1016/j.acra.2013.02.012.

PMID:
23746384
8.

Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.

Nguyen HT, Jia G, Shah ZK, Pohar K, Mortazavi A, Zynger DL, Wei L, Yang X, Clark D, Knopp MV.

J Magn Reson Imaging. 2015 May;41(5):1374-82. doi: 10.1002/jmri.24663.

10.

Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.

Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, Suzuki K, Oshima H, Hara M, Shibamoto Y.

Radiology. 2009 Apr;251(1):112-21. doi: 10.1148/radiol.2511080873.

PMID:
19332849
11.

Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.

Mendichovszky IA, Cutajar M, Gordon I.

Eur J Radiol. 2009 Sep;71(3):576-81. doi: 10.1016/j.ejrad.2008.09.025.

PMID:
19004588
12.

3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.

Rischke HC, Nestle U, Fechter T, Doll C, Volegova-Neher N, Henne K, Scholber J, Knippen S, Kirste S, Grosu AL, Jilg CA.

Radiat Oncol. 2013 Jul 22;8:183. doi: 10.1186/1748-717X-8-183.

13.

Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.

Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.

AJR Am J Roentgenol. 2007 Oct;189(4):849.

PMID:
17885055
14.

Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.

Othman AE, Falkner F, Martirosian P, Schraml C, Schwentner C, Nickel D, Nikolaou K, Notohamiprodjo M.

Invest Radiol. 2016 Feb;51(2):106-12. doi: 10.1097/RLI.0000000000000213.

PMID:
26447494
15.

Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.

Braunagel M, Radler E, Ingrisch M, Staehler M, Schmid-Tannwald C, Rist C, Nikolaou K, Reiser MF, Notohamiprodjo M.

Invest Radiol. 2015 Jan;50(1):57-66. doi: 10.1097/RLI.0000000000000096.

PMID:
25260094
16.

Evaluation of international federation of gynecology and obstetrics stage IB cervical cancer: comparison of diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging at 3.0 T.

Lin Y, Chen Z, Kuang F, Li H, Zhong Q, Ma M.

J Comput Assist Tomogr. 2013 Nov-Dec;37(6):989-94. doi: 10.1097/RCT.0b013e3182990a65.

PMID:
24270123
17.

Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer.

Yoshida S, Koga F, Kawakami S, Ishii C, Tanaka H, Numao N, Sakai Y, Saito K, Masuda H, Fujii Y, Kihara K.

Urology. 2010 Feb;75(2):387-91. doi: 10.1016/j.urology.2009.06.111.

PMID:
19914691
18.

Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.

Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30.

PMID:
17881141
19.

Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.

Braren R, Curcic J, Remmele S, Altomonte J, Ebert O, Rummeny EJ, Steingoetter A.

Invest Radiol. 2011 Oct;46(10):624-31. doi: 10.1097/RLI.0b013e31821e30e7.

PMID:
21577121
20.

Free-breathing dynamic contrast-enhanced MRI of the abdomen and chest using a radial gradient echo sequence with K-space weighted image contrast (KWIC).

Kim KW, Lee JM, Jeon YS, Kang SE, Baek JH, Han JK, Choi BI, Bang YJ, Kiefer B, Block KT, Ji H, Bauer S, Kim C.

Eur Radiol. 2013 May;23(5):1352-60. doi: 10.1007/s00330-012-2699-4.

PMID:
23187728
Items per page

Supplemental Content

Support Center